Zevra Therapeutics, Inc. (ZVRA)
10.12
+0.06
(+0.65%)
USD |
NASDAQ |
Oct 28, 13:09
Zevra Therapeutics Market Cap : 600.54M for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 596.68M |
| October 26, 2026 | 565.53M |
| October 23, 2026 | 582.14M |
| October 22, 2026 | 613.00M |
| October 21, 2026 | 614.78M |
| October 20, 2026 | 621.31M |
| October 19, 2026 | 602.91M |
| October 16, 2026 | 589.86M |
| October 15, 2026 | 609.44M |
| October 14, 2026 | 607.07M |
| October 13, 2026 | 616.56M |
| October 12, 2026 | 671.75M |
| October 09, 2026 | 675.90M |
| October 08, 2026 | 652.76M |
| October 07, 2026 | 657.51M |
| October 06, 2026 | 636.74M |
| October 05, 2026 | 634.96M |
| October 02, 2026 | 592.83M |
| October 01, 2026 | 604.10M |
| September 30, 2026 | 650.98M |
| September 29, 2026 | 672.94M |
| September 28, 2026 | 670.56M |
| September 25, 2026 | 655.13M |
| September 24, 2026 | 668.19M |
| September 23, 2026 | 671.75M |
| Date | Value |
|---|---|
| September 22, 2026 | 687.18M |
| September 21, 2026 | 692.52M |
| September 18, 2026 | 688.96M |
| September 17, 2026 | 702.61M |
| September 16, 2026 | 700.23M |
| September 15, 2026 | 691.33M |
| September 14, 2026 | 715.07M |
| September 11, 2026 | 712.70M |
| September 10, 2026 | 715.66M |
| September 09, 2026 | 714.48M |
| September 08, 2026 | 752.16M |
| September 04, 2026 | 735.84M |
| September 03, 2026 | 744.15M |
| September 02, 2026 | 729.91M |
| September 01, 2026 | 715.66M |
| August 31, 2026 | 696.67M |
| August 28, 2026 | 686.29M |
| August 27, 2026 | 703.20M |
| August 26, 2026 | 696.67M |
| August 25, 2026 | 714.48M |
| August 24, 2026 | 691.33M |
| August 21, 2026 | 704.39M |
| August 20, 2026 | 705.58M |
| August 19, 2026 | 719.82M |
| August 18, 2026 | 686.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Innoviva, Inc. | 1.529B |
| Xeris Biopharma Holdings, Inc. | 1.861B |
| ANI Pharmaceuticals, Inc. | 1.628B |
| Corcept Therapeutics, Inc. | 9.438B |
| Veru, Inc. | 38.53M |
Market Cap Related Metrics
| PE Ratio | 10.92 |
| PS Ratio | 4.418 |
| Price to Book Value | 2.759 |
| Price to Free Cash Flow | 18.43 |
| Price | 10.12 |
| Earnings Yield | 9.16% |
| Operating PE Ratio | 15.39 |
| Normalized PE Ratio | 8.921 |